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ABSTRACT Interactions between the gut microbiome and immunoglobulin A (IgA)
in the gut during infancy are important for future health. IgM and IgG are also pres-
ent in the gut; however, their interactions with the microbiome in the developing
infant remain to be characterized. Using stool samples sampled 15 times in infancy
from 32 healthy subjects at 4 locations in 3 countries, we characterized patterns of
microbiome development in relation to fecal levels of IgA, IgG, and IgM. For 8 in-
fants from a single location, we used ﬂuorescence-activated cell sorting of microbial
cells from stool by Ig-coating status over 18 months. We used 16S rRNA gene proﬁl-
ing on full and sorted microbiomes to assess patterns of antibody coating in relation
to age and other factors. All antibodies decreased in concentration with age but
were augmented by breastmilk feeding regardless of infant age. Levels of IgA corre-
lated with relative abundances of operational taxonomic units (OTUs) belonging to
the Biﬁdobacteria and Enterobacteriaceae, which dominated the early microbiome,
and IgG levels correlated with Haemophilus. The diversity of Ig-coated microbiota
was inﬂuenced by breastfeeding and age. IgA and IgM coated the same microbiota,
which reﬂected the overall diversity of the microbiome, while IgG targeted a differ-
ent subset. Blautia generally evaded antibody coating, while members of the Biﬁdo-
bacteria and Enterobacteriaceae were high in IgA/M. IgA/M displayed similar dynam-
ics, generally coating the microbiome proportionally, and were inﬂuenced by
breastfeeding status. IgG only coated a small fraction of the commensal microbiota
and differed from the proportion targeted by IgA and IgM.
IMPORTANCE Antibodies are secreted into the gut and attach to roughly half of the
trillions of bacterial cells present. When babies are born, the breastmilk supplies
these antibodies until the baby’s own immune system takes over this task after a
few weeks. The vast majority of these antibodies are IgA, but two other types, IgG
and IgM, are also present in the gut. Here, we ask if these three different antibody
types target different types of bacteria in the infant gut as the infant develops from
birth to 18 months old and how patterns of antibody coating of bacteria change
with age. In this study of healthy infant samples over time, we found that IgA and
IgM coat the same bacteria, which are generally representative of the diversity pres-
ent, with a few exceptions that were more or less antibody coated than expected.
IgG coated a separate suite of bacteria. These results provide a better understanding
of how these antibodies interact with the developing infant gut microbiome.
KEYWORDS gut microbiome, infant, diabetes, immunoglobulins, IgA, IgM, IgG,
antibody coating, infant gut development, FACS, host response, immunology,
microbial ecology
The gut microbiota, the immune system, and their interactions develop in tandem ininfancy (1, 2). The immunoglobulin A (IgA) component of breast milk is protective
against infection in infants and may also direct the development of the gut microbiota.
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IgA is secreted into the gut lumen, where it binds antigens from food and microbiota,
thereby excluding them from direct contact with the host epithelial cells (3). At birth,
neonates generally have undetectable IgA in meconium (4), and it takes a few weeks
for their immune systems to initiate IgA production and secretion into the gut (5).
Breastmilk is an important early source of IgA, and breastfeeding is associated with high
levels of fecal IgA in infants (4, 6). Planer et al. characterized the fraction of IgA-coated
fecal microbiota in infants over the ﬁrst few years of life and reported differences
between breastmilk- and formula-fed infants, which may relate to differences in how
the microbiota develop in these two groups (7).
Although IgA is the dominant antibody in the gut, IgM and IgG are also present. The
juvenile gut sees up to 5 g of secretory IgA daily, 100-fold less secretory IgM, and
1,000-fold less IgG (8). IgM and IgA are both produced by B cells locally, and the
predominant class switching that occurs in B cells of the gut-associated lymphoid tissue
is from IgM to IgA. Both are secreted into the gut via the same mechanism (polymeric
Ig receptor), IgM as a pentamer and IgA as a dimer. In contrast, IgG is the most common
antibody in circulation but can also be transported into the gut via a neonatal Fc
receptor (9). Whereas IgA/M are produced in response to luminal microbial epitopes
that are sampled by dendritic cells, IgG induction is thought to require crossing of the
barrier by antigens, such that IgG is not produced continuously in response to common
gut antigens.
Based on its similarity to IgA, IgM may be expected to follow similar patterns of
microbiota binding, whereas IgG may not. In healthy adults, IgA has been shown to
coat a greater proportion of the stool microbiota than IgG or IgM, but whether the
diversity of taxa targeted by these antibodies differs has not been reported (10). To gain
a baseline understanding of how IgA, IgG, and IgM coat gut microbiota during
microbiome development in infancy, here we performed a longitudinal analysis of the
fecal microbiome of healthy infants in which we characterized the diversity of micro-
biota coated with IgA, IgM, and IgG as a function of time and with respect to feeding
regimen and antibody levels.
RESULTS
The small sample set is representative of the larger TEDDY population. We
looked for previously reported patterns of microbiota diversity in relation to covariates
in order to establish that the small cohort used here (32 subjects sampled longitudi-
nally, unsorted stool) is representative of the larger TEDDY cohort. More information on
the study participants is shown in Table 1. Two recent papers have reported on the gut
microbiome in the TEDDY cohort: Stewart et al. (11) employed a 16S rRNA gene survey
on 903 subjects, and Vatanen et al. (12) used metagenomics with 783 subjects. Our
results recapitulate those of Stewart et al. and Vatanen et al. in the following ways: (i)
Biﬁdobacteriaceae and Enterobacteriaceae dominated the infant gut at early time points,
while Firmicutes increased in relative abundance later (Fig. 1); (ii) breastfeeding status
was signiﬁcantly associated with between-sample diversity (e.g., beta diversity, as
observed from associations between breastfeeding status and several principal coor-
dinates [PCs] from both unweighted and weighted UniFrac principal coordinate anal-
TABLE 1 Characteristics of study participantsa
Parameter
Value for study participant
No. sampled Means  SEM Median Range
Baby birth weight (g) 31 3,526.34  80.33 3,505 2,620–4,480
Mother body mass index 32 26.26  1.08 24.34 17.83–47.3
Gestational age (wk) 32 39.81  0.23 40 37–42.14
Mother weight gain (kg) 32 15.24  1.06 14.45 5.91–28.6
Maternal age 32 33.31  0.99 31.5 22–43
Paternal age 31 34.74  0.79 34 27–43
aLocation, Georgia (USA, n 8), Washington (USA, n 8), Germany (n 8), and Sweden (n 8); delivery
mode, Caesarian (n 8), vaginal (n 23), unknown (n 1); sex, female (n 16) and male (n 16).
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ysis [PCoA]; Fig. 2 and 3; see also Table S1 in the supplemental material) after correcting
for multiple testing; (iii) the only other factor with a signiﬁcant association with beta
diversity was geographic location (Fig. 4A); (iv) we observed a weak association
between antibiotic exposure and beta diversity (unweighted UniFrac PC4; Fig. 4B and
C); (v) age had a signiﬁcant association with microbiome richness (Chao1, Faith’s
phylogenetic diversity, observed species, and Gini coefﬁcient; all P 1010). We ob-
served that age and breastfeeding status were associated with microbiome diversity,
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FIG 1 Changes in microbial composition over time. (A and B) Percent relative abundance of the dominant bacterial phyla (A) and
families (B) in the unsorted samples (top plot in each panel). Each of the four quadrants is plotted over time. Q1 (IgAM), IgA and
IgM both high, IgG low; Q2 (IgAMG), all high; Q3 (Ig), all low; Q4 (IgG), IgG high, IgA and IgM both low.
Ig-Coated Bacteria in the Developing Infant Gut
November/December 2019 Volume 4 Issue 6 e00612-19 msystems.asm.org 3
 o
n
 January 7, 2020 at TAM
PERE UNIVERSITY LIBRARY
http://m
system
s.asm
.org/
D
ow
nloaded from
 
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
100
200
300
400
500
Age (Days)
A
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
Clinical Center Location
Georgia
Germany
Sweden
Washington
B
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
Delivery mode
Caesarian
Vaginal
NA
C
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
3000
3500
4000
Baby birth weight (g)
D
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
20
30
40
Mother BMI
E
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
HLA Group
DR4/4
DR4/3
DR3/3
F
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
Breastfeeding status
No
Yes
G
−0.2
0.0
0.2
0.4
−0.3 −0.2 −0.1 0.0 0.1 0.2 0.3
PC1
PC
2
25
50
75
100
125
Phylogenetic Diversity
H
FIG 2 Patterns of beta diversity (using unweighted UniFrac) in 32 infant time series with covariates visualized. Shown are the ﬁrst two axes (PC1 and
PC2) from principal coordinate analysis of the unweighted UniFrac distances among the unsorted fecal microbiome samples of 32 infants over the
ﬁrst couple years of life. Points are colored by participant characteristics and phylogenetic diversity. (A) Infant age in days at the time of sampling.
(B) Geographic location of the TEDDY-associated primary care center where samples were collected; this includes samples from Germany, Sweden,
(Continued on next page)
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corroborating the ﬁndings of previous studies (11, 12), and therefore the subset of
subjects that we used in subsequent analysis are representative of the larger TEDDY
cohort.
Stool antibody levels decrease with infant age and are related to breastfeeding
status. We observed that levels of IgA, IgG, and IgM (measured by enzyme-linked
immunosorbent assay [ELISA] in the same stool samples for which the microbiome was
analyzed) were positively correlated to each other across the sample set (Fig. S1). Age
(and therefore also microbiome alpha diversity) was negatively correlated with levels of
IgA (repeated measures correlation [rrm]  0.45, P 6.14  1022), IgG (rrm  0.37,
P 1.13  1014), and IgM (rrm  0.23, P 3.29  105), although the IgG and IgM
correlation with age was not as strong as that for IgA (Fig. S1). No association of
geographic location or HLA genotype was observed with any of the immunoglobulin
levels in stool.
We assessed the relationships between stool IgA levels, age, and breastfeeding
status to ask how IgA levels varied over time. We were particularly curious to see if the
cessation of breastfeeding correlated with stool IgA levels and if the effect of breast-
feeding was age dependent. We observed that IgA levels in stool decreased signiﬁ-
cantly with age (P 1.79  1011) (Fig. 5 and 6). Furthermore, we observed that
breastfeeding was signiﬁcantly associated with higher stool IgA levels (P 0.039), and
that this association was not dependent on the age of the infants. These observations
corroborate previous reports that IgA levels decrease with age, but that at any age,
breastmilk delivers additional IgA to the infant.
We next examined the association between stool levels of IgA, IgG, and common
OTUs (e.g., those shared by greater than 40% of samples) (Fig. 6). IgA levels were
positively associated with several Enterobacteriaceae OTUs and a few Biﬁdobacteriaceae
OTUs. Only one OTU was associated with IgG levels in feces. This OTU belonged to
genus Haemophilus (Benjamini-Hochberg [BH] adjusted P 1.66  103).
IgA and IgM coat many of the same microbial cells. For 8 infants from Georgia,
for whom 15 time points sampled over 18 months were available, we sorted cells
according to their antibody-coating status using FACS based on their distributions in
four quadrants (Qs) (Text S1). The gatings for these four populations and the resulting
quadrants are illustrated in Fig. 7A and B. We used heavy-chain-speciﬁc antibodies that
do not cross-react with other classes of Ig (Text S1); thus, the patterns observed by ﬂow
cytometry indicate that many microbial cells were tagged with multiple antibodies. The
gating patterns indicate that IgA and IgM coat many of the same cells, since the
patterns of coating overlap. IgG-coated cells, on the other hand, fell into three cate-
gories: IgAM, those low in IgG and high in IgA/IgM; IgAMG, those highly coated in
IgG, IgA, and IgM; Ig, uncoated cells; and IgG, those highly coated in IgG and low
in IgA/IgM. We observed that the correlation between IgA and IgM coating was
consistently higher than the correlation between IgA and IgG coating across sampling
time points (P 1010) (Fig. 7C).
Speciﬁc taxa discriminate total and FACS-sorted populations. We compared the
diversity of the sorted microbiota (all Qs combined) to that of the whole microbiota
(unsorted) to assess the impact of the FACS process on microbial diversity. We observed
that the microbiota composition of the sorted cells (all Qs) is distinct from that of the
total microbiome: a combined PCoA analysis of unweighted UniFrac analysis shows
clear separation of unsorted and sorted cells along PC2 (Fig. 8A). The unsorted
population was richer (Chao1, phylogenetic diversity, and observed species) and ex-
hibited greater evenness (Gini coefﬁcient) than all sorted cells (P 1010 for all metrics)
FIG 2 Legend (Continued)
and the United States (Georgia and Washington). (C) Vaginal or cesarean delivery. (D) Baby birth weight in grams. (E) Body mass index (BMI) of the
mother before pregnancy. (F) HLA genotypes of the infant were DR4-DQA1*030X-DQB1*0302/DR3-DQA1*0501-DQB1*0201 (DR3/4), DR4-DQA1*030X-
DQB1*0302/DR4-DQA1*030X-DQB1*0302 (DR4/4), and DR3-DQA1*0501-DQB1*0201/DR3-DQA1*0501-DQB1*0201 (DR3/3). (G) Breastfeeding status at the
time of sampling. (H) Faith’s phylogenetic diversity. In all plots colored by a quantitative trait, blue indicates lower values and red indicates higher
values.
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FIG 3 Patterns of beta diversity (using weighted UniFrac) in 32 infant time series with covariates visualized. Shown are the ﬁrst two axes (PC1 and
PC2) from principal coordinate analysis of the weighted UniFrac distances between the unsorted fecal microbiome samples of 32 infants over the
ﬁrst couple years of life. Points are colored by participant characteristics and phylogenetic diversity. (A) Infant age in days at the time of sampling.
(B) Geographic location of the TEDDY-associated primary care center where samples were collected; this includes samples from Germany, Sweden,
and the United States (Georgia and Washington). (C) Vaginal or cesarean delivery. (D) Baby birth weight in grams. (E) Body mass index (BMI) of the
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(Fig. S2). We applied linear mixed models to identify taxa that were differentially
abundant between the unsorted and sorted populations (all Qs). This analysis identiﬁed
members of the Bacteroidetes, Verrucomicrobia, Gammaproteobacteria, and most Firmi-
cutes as comparatively enriched in the unsorted fraction and Actinobacteria and Alp-
haproteobacteria as enriched in the sorted fraction (Fig. 8C). The difference in compo-
sition between sorted and unsorted fractions likely stems from the FACS process itself;
for example, cells belonging to Actinobacteria and Alphaproteobacteria may be less
likely to clump than others. Thus, the difference between sorted and unsorted micro-
biomes introduces the caveat that subsequent analyses with the sorted data are
performed on a subset of the microbiome.
Antibody-targeted cells exhibit patterns similar to those of the total popula-
tion. As observed for unsorted cells, the majority of the variation in the sorted cells (PC1
of the unweighted UniFrac PCoA) was explained by age (Fig. 8B). Similarly, as age
increased, alpha diversity also increased (Fig. S3). Analysis of variance indicated that
FACS quadrant was signiﬁcantly associated with most of the ﬁrst 10 PCs from the PCoA
(restricted to only sorted 16S rRNA gene data) of both unweighted and weighted
UniFrac and all four alpha diversity metrics. Post hoc pairwise comparisons showed that
this association was driven primarily by a difference between IgG (high IgG only) and
the other three quadrants. This ﬁnding might represent an overall diversity difference
between the high IgG-only cells and others. However, the number of cells sorted into
the high-IgG (IgG) quadrant was signiﬁcantly lower than those of the other three
quadrants (Fig. S3). Indeed, most of the cells coated in IgG were also coated by IgA and
IgM and are therefore sorted into IgAMG rather than IgG. This signiﬁcant difference
in cell number between the quadrants could explain the difference in diversity ob-
served between IgG and the other three quadrants.
After exclusion of IgG (high-IgG only), we observed some signiﬁcant associations
between the ﬁrst 10 PCs of the beta diversity PCoAs and the FACS quadrant, as well as
several associations with infant age and infant breastfeeding status. The signiﬁcant
associations with unweighted UniFrac were with age (PCs 1, 2, and 3), breastfeeding
status (PCs 1, 2, 3, 6, and 7), and FACS quadrant (PCs 7 and 10) (Table S2). Further
analysis of the FACS quadrant associations showed that Ig (uncoated) was different
from both IgAM (P 0.030) and IgAMG (P 0.001) along PC7, and that IgAMG
differed from Ig (P 0.010) along PC10 (post hoc pairwise comparisons between the
quadrants using Tukey’s honestly signiﬁcant difference [HSD] method to adjust for
multiple comparisons). Among the weighted UniFrac PCs, many are associated with
FACS quadrant (PCs 1, 5, 7, 8, and 9; post hoc analysis shows that Ig is different from
IGAM and IgAMG) and PC1 is associated with breastfeeding status and PC2 with
age (Table S2). These results indicate that the diversity of cells targeted by antibodies
is inﬂuenced by breastfeeding status and infant age. Furthermore, the speciﬁc combi-
nation of antibodies on the cells is not random.
Speciﬁc taxa vary in their antibody-coating proﬁles. We next identiﬁed speciﬁc
OTUs differentially abundant between the quadrants. To identify common OTUs (i.e.,
OTUs with nonzero sequence counts in greater than 40% of FACS samples examined)
with differential relative abundance between quadrants, we performed linear mixed
models using each OTU as a response variable. We searched for differences between
the coated (IgAM and IgAMG; excluding IgG because of low cell population) and
uncoated (Ig) populations. When comparing IgAM to Ig Qs, we observed signif-
icant differences in the relative abundances of 80 out of 190 OTUs (Fig. 9 and Table S3).
These mostly included OTUs classiﬁed as Blautia, which had higher relative abundance
in Ig (uncoated) than other Qs. OTUs that were higher in IgAM (IgM and IgA both
FIG 3 Legend (Continued)
mother before pregnancy. (F) HLA genotypes of the infant were DR4-DQA1*030X-DQB1*0302/DR3-DQA1*0501-DQB1*0201 (DR3/4), DR4-DQA1*030X-
DQB1*0302/DR4-DQA1*030X-DQB1*0302 (DR4/4), and DR3-DQA1*0501-DQB1*0201/DR3-DQA1*0501-DQB1*0201 (DR3/3). (G) Breastfeeding status at the
time of sampling. (H) Faith’s phylogenetic diversity. In all plots colored by a quantitative trait, blue indicates lower values and red indicates higher
values.
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high) were mostly classiﬁed as Biﬁdobacterium, unclassiﬁed Enterobacteriaceae, and
Ruminococcus gnavus. Similarly, 101 OTUs had differential relative abundances between
IgAMG (all high) and Ig (all low), with Blautia being signiﬁcantly higher in Ig
(Table S4).
−0.10
−0.05
0.00
0.05
0.10
5 10 15
Age (months)
PC
7
Geographic location
Georgia
Germany
Sweden
Washington
A
−0.10
−0.05
0.00
0.05
0.10
5 10 15
Age (months)
PC
4
Antibiotic exposure
No
Yes
B
Has had antibiotic exposure
Has not had antibiotic exposure
5 10 15
1800
2400
2600
3000
3800
4300
4400
4600
5000
5400
6400
8700
9600
10300
10600
11300
11800
13200
1600
2000
2900
3500
4000
5200
5600
6000
10500
10800
12700
13500
13800
14800
Age (months)
Su
bje
ct 
ID
Stool
Antibiotics
Antibiotic class
Beta−lactams
Cephalosporin
Macrolide
Sulphamethoxazole +
Trimethoprim
Trimethoprim
NA
C
FIG 4 Beta diversity measures in relation to age. (A and B) PC4 (A) or PC7 (B) of unweighted UniFrac distances across time points. Lines show
the mean PC values  SEM grouped by time point and geographic location (A) or previous antibiotic exposure (B). (C) Plot illustrating the time
of stool collection and antibiotic use for each participant. NA, not applicable.
Janzon et al.
November/December 2019 Volume 4 Issue 6 e00612-19 msystems.asm.org 8
 o
n
 January 7, 2020 at TAM
PERE UNIVERSITY LIBRARY
http://m
system
s.asm
.org/
D
ow
nloaded from
 
Cross-validation for IgA-targeted microbiota. We compared the results of our
analysis with those of Planer et al., who used FACS followed by 16S rRNA gene
sequencing to characterize the IgA coated microbes of 40 twin pairs over the ﬁrst
couple years of life (7). We used the same reference database as Planer et al. to classify
sequences; therefore, we could compare OTUs directly. A total of 14 individual OTUs
were identiﬁed by Planer et al. as being consistently targeted or not targeted by IgA
(n 5 and n 9, respectively). Of these OTUs, two met the same criteria as those used
in this study, in that they had a nonzero value in 40% of the samples. Interestingly,
both OTUs behaved similarly with respect to antibody coating. Greengenes OTU
365385 (genus Biﬁdobacterium), consistently targeted by IgA in the Planer et al. study,
was proportionally higher in both IgAM (BH adjusted P 3.07 1005) (Fig. 9A) and
IgAMG (BH adjusted P 1.88 1005) than Ig. The other Greengenes OTU de-
tected in both data sets (606927; family Peptostreptococcaceae) was consistently non-
targeted by IgA in the Planer et al. study, and similarly, we observed this OTU to have
a higher relative abundance in Ig (uncoated) than IgAMG (BH adjusted P 0.013)
(Table S4). These comparisons indicate that taxon-speciﬁc antibody-coating proﬁles can
be generalizable across studies.
DISCUSSION
Interactions between IgA and the gut microbiome in the developing gut are
important for health. Indeed, low levels in IgA coating of the gut microbiome in infants
is associated with development of allergies and asthma during childhood (13) and with
Crohn’s disease in children (14). Although the dynamics of IgA levels in the infant gut
over time, and in response to breastfeeding, are well characterized, the IgA-microbiota
coating, and those of the other antibodies in the gut (IgM and IgG), are less well
understood. This study provides a baseline view of how levels of IgA, IgG, and IgM
correlate with age and other factors over the ﬁrst 18 months of life in healthy Western
children and details how speciﬁc taxa are targeted by these antibodies over time in a
subset of children.
This study included infants from four distinct geographic locations, two in the
United States and two in Europe. Infants from the different locations had slightly
different microbiota, as previously reported (11, 12). Effects of breastfeeding status on
the microbiome and antibody levels, and the decrease in antibody levels with age, were
also similar across subjects, regardless of the shift in diversity associated with the
geographic location of the infants. We also observed a strong impact of breastfeeding
status and age on gut microbial community structure, as previously reported (11, 12).
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FIG 5 Infant fecal IgA concentrations over the ﬁrst couple years of life. PC1 from the PCoA of the fecal microbiome unweighted
UniFrac distances is plotted against the age of the infant in days at the time of sampling. The points are colored by the
log-transformed fecal IgA concentrations; lower concentrations are blue and higher concentrations are red.
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In contrast, we did not observe an effect of birth mode on microbiome diversity in this
data set.
Our longitudinal analysis of the Georgia infants’ gut microbiota targeted by anti-
bodies over time revealed that IgM and IgA target the same microbial populations. IgA
and IgM targeting of the same cell population implies these two antibodies can be
induced via the same mechanism, and that, like IgA, IgM induction is a local phenom-
enon. In contrast, we observed patterns of IgG coating quite distinct from those of IgA
and IgM. IgG is induced as a result of the systemic immune system’s recognition of a
“non-self” antigen and is not, in general, produced locally in the gut. Thus, whereas
IgA/M responses mirror the gut microbiome generally, the bacterial targets of IgG are
Bifidobacteriaceae
Bacteroidaceae
Enterococcaceae
Streptococcaceae
Unclassified Clostridiales
Clostridiaceae
Lachnospiraceae
Ruminococcaceae
Veillonellaceae
Erysipelotrichaceae
Enterobacteriaceae
***
***
***
*
***
**
***
*
***
***
*
***
*
***
***
**
**
**
**
***
**
***
***
***
***
***
***
***
***
***
***
***
***
**
***
***
***
***
***
***
***
***
**
***
***
***
**
**
***
*
***
***
*
**
*
*
*
*
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
**
***
***
***
***
***
***
***
***
***
***
*
***
***
***
***
**
*
**
*
*
**
**
*
***
*
**
***
*
*
*
**
***
***
***
***
*
**
***
***
***
*
***
*
***
*
**
*
***
**
**
**
*
***
*
*
*
**
**
*
*
*
*
**
*
***
*
***
**
***
***
**
*
**
*
***
**
*
**
*
**
**
***
**
**
**
**
***
**
*
*
*
**
***
*
***
**
***
***
***
***
***
***
***
*
***
***
***
**
***
*
*
*
***
***
*
**
*
**
***
***
***
***
***
***
***
***
***
***
***
***
***
**
***
***
***
***
***
***
*
**
*
*
***
***
*
**
*
*
**
***
*
**
*
***
*
***
***
***
***
***
***
***
*
***
***
***
***
***
***
**
***
***
***
***
*
*
**
*
***
**
***
***
**
*
***
*
*
***
***
***
*
**
***
***
***
**
**
***
**
***
***
***
**
***
**
*
*
**
*
*
**
*
**
***
**
*
***
**
**
***
***
***
***
*
*
***
**
***
**
***
*
***
***
***
***
*
Age
log(µg IgA/ g Stool)
log(µg IgG/ g Stool)
Breastfeeding Status
Age
*Breastfeeding
15
10
5
0
5
10
15
−log10(pvalue)
Positive
association
Negative 
association
FIG 6 Associations of age, fecal IgA and IgG concentrations, and breastfeeding status with common OTUs in the infant
fecal microbiomes. Heatmap showing, along the vertical axis, each of the common OTUs (nonzero value in 40% of
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related to those targeted by the systemic immune system around the time of collection.
We noted a fair amount of overlap between the IgA/M- and IgG-coated fractions,
however, suggesting redundancy across all three classes of antibody.
The majority of IgA secreted to the gut is polyclonal and thought to be relatively
unselective, as it binds with epitopes that are widely shared among gut bacteria (15,
16). In addition, secretory IgA afﬁnity maturation by somatic hypermutation is a
prominent feature of the human repertoire (17), and a large fraction of secretory IgA
may be targeted to speciﬁc bacterial species (18). Using a reversible colonization system
in germfree mice, Hapfelmeier and colleagues showed that a speciﬁc strain of E. coli
induced a sustained IgA response even after the strain was no longer there
(100 days), but that colonization with other bacteria induced a decline in the Esche-
richia coli-speciﬁc IgA and an increase in IgA response to the newly introduced bacteria
(19). These results suggested the presence of a long-lived compartment of IgA-
secreting plasma cells in the intestinal lamina propria but that the compartment has a
ﬁnite size, so that the IgA secreted into the intestine depends on the dominant luminal
A
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FIG 7 IgA and IgM coat many of the same microbial cells. (A) Representative data for FACS sorting of microbial cells in infant fecal samples. Frequencies of
IgM- versus IgA-tagged cells (green and red, respectively). (B) This panel shows how the four quadrants were gated. IgAM, IgA and IgM both high; IgAMG,
all three high; Ig, all three low; IgG, IgG high, others low. (C) Box plots at each time point of the Pearson correlations (y axis) between IgA and IgM signals
and between IgA and IgG signals from the FACS sorting of each fecal sample.
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FIG 8 Fecal microbiome composition is altered by FACS but remains signiﬁcantly associated with infant age. (A) PCoA of unweighted UniFrac distances colored
by FACS quadrant. Unsorted samples are shown in gray. (B) The same PCoA plot of unweighted UniFrac distances colored by participant age. (C) Summary of
taxa that are differentially abundant between the total (red) and FACS (green) populations.
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microbial species. Based on this model, we would expect the majority of the IgA-coated
fraction of microbiota to mirror the unsorted microbiota (although a small subset of
taxa exhibit either more or less coating than expected based on this model; see below),
and allowing for the caveats of FACS sorting, this is the general pattern that we
observed.
A few OTUs provided exceptions to the general pattern, in that some OTUs were
more highly represented in the IgA-coated than uncoated (Ig) cell populations. In
particular, OTUs classiﬁed as Biﬁdobacterium, unclassiﬁed Enterobacteriaceae, and Ru-
minococcus gnavus had higher representation in the IgA-coated cell fraction. In addi-
tion, we observed that levels of IgA antibody in stool were correlated to a few
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FIG 9 Many differentially abundant OTUs between quadrants 1 (IgAM, IgM and IgA both high) and quadrant 3 (Ig, low coating) are classiﬁed as Blautia
and Biﬁdobacterium. (A and B) Plots for a subset of differentially abundant OTUs between Q1 and Q3 illustrating higher relative abundance of Biﬁdobacterium
OTUs in Q1 (IgAM) (A) and higher relative abundance of Blautia OTUs in Q3 (B). Plots on the left show the log(Q1 OTU abundance)  log(Q3 OTU abundance)
divided by log(Q1 OTU abundance)  log(Q3 OTU abundance) over time, where each point represents a sample and is colored by time point. Positive values
on the y axis indicate enrichment of the OTU abundance in Q1 (IgAM), and negative values indicate enrichment of the OTU abundance in Q3 (Ig); this is
similar to the IgA index deﬁned in Planer et al. (7). Plots on the right show the average of the log-transformed OTU relative abundance in Q1 (IgAM, red) and
Q3 (Ig, blue) at each time point. OTU Greengenes ID, taxonomic classiﬁcation, and P value from the linear mixed model using OTU as a response variable
are indicated above each set of graphs. Only common OTUs (nonzero value in 40% of samples tested) were tested.
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Biﬁdobacteriaceae OTUs and several Enterobacteriaceae OTUs. Planer et al. also observed
one of the same OTUs was highly coated in IgA in the fecal samples of children from
Malawi (7), and Biﬁdobacteria in particular have been shown to induce high levels of IgA
in the gut (20). Biﬁdobacteria and Enterobacteriaceae dominated the infant gut micro-
biomes early on; however, the higher-than-expected levels of speciﬁc OTUs belonging
to these taxa in the IgA-coated fraction suggests they are stimulating IgA production
speciﬁc to them in excess of what is expected from their relative abundances in the
microbiota. Alternatively, given that here we characterize antibody coating of bacteria
in the feces, these taxa may be preferentially cleared from the intestine once coated
with IgA. Antibody coating is implicated in aggregation, which may help retain bacteria
in mucus, as well as clearance, because larger particles are more likely to be entrained;
it is likely that both mechanisms operate simultaneously and differentially for various
taxa.
In contrast to the high-IgA-coated microbiota, OTUs classiﬁed as Blautia showed a
lack of antibody coating. In the healthy mouse cecum, speciﬁc OTUs have been shown
to be less coated than what would be expected by chance (21). One explanation could
be antibody evasion by regulation of epitopes in response to the antibodies. Certain
bacterial species, including the gut commensal Bacteroides thetaiotaomicron, have been
shown to downregulate the expression of epitopes in response to IgA (22–24). Alter-
natively, the relative undercoating of speciﬁc taxa in stool may reﬂect patterns of
clearance, and here uncoated Blautia OTUs are more likely to be shed than their coated
counterparts. How IgA coating relates to the microbial ecology of the microbiota, their
growth rates, the immune response to speciﬁc epitopes, and ultimately shedding of the
cells is complex and not well understood.
Although a large proportion of sorted cells was coated by all three antibodies, we
did observe differences between the patterns of IgG coating and the patterns of
IgA/IgM coating (note that the low cell count, approximately 5% of the total popula-
tion, in the IgG-only coated category casts some doubt on the reliability of these
results). One OTU was associated with IgG levels in feces; this OTU belonged to the
genus Haemophilus. IgG is produced systemically in response to infection, and it is also
produced in response to immunization. Thus, this pattern may have resulted from the
Haemophilus vaccine, which is given to infants. It is one of the few vaccines against a
bacterium, and it is not a mucosal vaccine. Haemophilus colonizes the upper respiratory
mucosa, and not all are pathogenic. The Haemophilus that we observed here may
include commensal species that share capsule epitopes with the vaccine strains.
One limitation of the present study is the relatively small sample sizes utilized, as
only 32 infants were studied for the overall microbiome effects, whereas 8 infants were
investigated for antibody-coating patterns over time. Although we recapitulate many
results of the developing infant gut from the TEDDY cohort in the unsorted microbiome
data with 32 samples, fewer studies have analyzed antibody coating of microbes within
the infant microbiome. The 8 infants investigated with respect to antibody coating
were selected from a single location; therefore, the patterns observed may not reﬂect
what is seen in other populations. Nevertheless, our study provides a foundation
toward further understanding how immune targeting of the gut microbiome may alter
microbiome development.
Our results indicate similar dynamics of antibody levels and microbiome develop-
ment with age and breastfeeding status in infants from different locations. Patterns of
IgA/M patterning indicate that sorting for IgM-coated cells are not any more informa-
tive than sorting for IgA alone. IgG coating of the infant gut microbiome may reveal
antigen exposure if gut microbes cross-react. These data provide a baseline reference
for further investigation of healthy or unhealthy children’s gut microbiomes in infancy.
MATERIALS AND METHODS
Subjects and selection criteria. This study was conducted using fecal samples collected by the
international type-1 diabetes (T1D) epidemiological prospective cohort study, The Environmental Deter-
minants of Diabetes in the Young (TEDDY) (25). Subjects were screened for T1D risk through HLA
genotyping, and all samples used in this study were collected from children with HLA genotypes that put
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them at high risk of developing T1D. None of the subjects included in the current study have developed
T1D or seroconverted for any of the 3 measured T1D-associated autoantibodies (glutamic acid decar-
boxylase autoantibodies, IA-2 autoantibodies, and insulin autoantibodies) by 24 months of age and had
not developed T1D by December 2016 (approximately 10 years of age). We focused on a set of
longitudinal stool samples (9 to 16 time points per subject) obtained from 32 age- and sex-matched
healthy children (468 fecal samples) from the United States (Georgia and Washington), Germany, and
Sweden. Subjects were excluded if they provided fewer than 12 longitudinal samples, if their participa-
tion and sample collection was through a long distance protocol, or if they dropped out of the study
before or at 24 months of age. Additional data collected as part of the TEDDY study and that were used
in the current analysis included physical descriptors (e.g., length and weight), diet, illnesses, hospital-
izations, vaccinations and medicines, and social data, such as daycare attendance.
Ethics approval and consent to participate. The study was approved by U.S. institutional review
boards and European ethics committee boards in the respective countries, which are the following:
Georgia’s Medical College of Georgia Human Assurance Committee (2004 to 2010), Georgia Health
Sciences University Human Assurance Committee (2011 to 2012), Georgia Regents University Institutional
Review Board (2013 to 2015), Augusta University Institutional Review Board (2015 to present), Washing-
ton State Institutional Review Board (2004 to 2012) and Western Institutional Review Board (2013 to
present), Germany’s Bayerischen Landesärztekammer (Bavarian Medical Association) Ethics Committee,
Sweden’s Regional Ethics Board in Lund, Section 2 (2004 to 2012), and Lund University Committee for
Continuing Ethical Review (2013 to present). Written informed consent was obtained for all study
participants from a parent or primary caregiver.
IgA, IgG, and IgM ELISAs. IgA, IgG, and IgM were quantiﬁed in duplicate for all fecal samples from
a subset of 8 infants from the Georgia study site. A serial dilution of reference human serum (Bethyl
Laboratories, Montgomery, TX) was used for generating a standard curve, and blocking buffer was used
as a negative control. The immunoglobulin concentrations were log transformed (with an offset of 0.01
added to IgM and IgG concentrations to handle zero values) before downstream analysis (see Text S1 in
the supplemental material).
FACS sorting of antibody-coated cells.Microbial FACS was performed on 117 fecal samples derived
from 8 subjects from the Georgia study site. Samples were vortexed and centrifuged to separate bacterial
cells from large particles and debris, and the resulting supernatant was transferred to a new tube. This
supernatant was then resuspended in phosphate-buffered saline (PBS) and centrifuged to remove
unbound immunoglobulins. The resulting pellet was then resuspended in PBS plus 0.1% bovine serum
albumin before labeling with the respective anti-IgA, anti-IgG, and anti-IgM ﬂuorophore-labeled anti-
bodies. Samples were incubated for 30 min and then washed twice prior to ﬂow cytometry and cell
sorting (see Text S1).
Microbial diversity analysis. Genomic DNA was extracted from 468 fecal samples (approximately
20 mg per sample) using the PowerSoil-htp DNA isolation kit (MoBio Laboratories Ltd., Carlsbad, CA). The
16S rRNA V4 hypervariable region was then PCR ampliﬁed (26), and the resulting amplicons were pooled
and sequenced using the Illumina MiSeq 2 250-bp paired-end platform at the Cornell Biotechnology
Resource Center Genomics Facility.
Sequence analysis was performed using the open-source software package QIIME 1.8.0 (Quantitative
Insights Into Microbial Ecology) (27). Brieﬂy, reads were quality ﬁltered before using open-reference OTU
picking at 97% against the Greengenes August 2013 database. The data were rareﬁed at 18,429
sequences per sample, which was the lowest sample sequencing depth over 1,000, in order to include
as many samples and sequences as possible (described in more detail in Text S1).
Statistical analyses. (i) Linear mixed models. All linear mixed-effects models were ﬁt using the
lme4 (28) package in R. Signiﬁcance was assessed using an F-test with a Satterthwaite approximation for
denominator degrees of freedom, calculated by the R package lmerTest. Post hoc pairwise comparisons
were performed using Tukey’s HSD tests implemented in the lsmeans (29) R package.
(ii) Association of subject characteristics with beta diversity and alpha diversity. A linear mixed
model was used for associating individual metadata with alpha and beta diversity. The only factors used
in the model examining the effect of time since exposure to oral antibiotics on unweighted UniFrac PC4
were age, time since oral antibiotic exposure, and the random effect for subject.
(iii) Correlations between immunoglobulin levels, age, and microbial diversity. The R package
rmcorr (30) was used to calculate pairwise repeated measures correlations (and their signiﬁcance)
between levels of IgA, IgG, and IgM, age, the ﬁrst three unweighted UniFrac PCoA PCs, and phylogenetic
diversity. A repeated measures correlation was used because it accounts for the multiple sampling of
individuals.
For further details, see Text S1.
Data availability. Raw sequencing data are available from the European Nucleotide Archive using
accession number PRJEB32930.
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